MAX BioPharma is a biopharmaceutical company developing small molecule lipids as candidates for therapeutic drugs. It is engaged in the discovery of osteogenic oxysterol compounds that target multipotent mesenchymal cells, including mesenchymal stem cells, to induce the formation of bone-forming osteoblasts and bone.